ACCESSIBILITY STATEMENT FOR SEELOS THERAPEUTICS
Seelos Therapeutics, Inc. is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards.
MEASURES TO SUPPORT ACCESSIBILITY
Seelos Therapeutics, Inc. takes the following measures to ensure accessibility of Seelos Therapeutics:
- Include accessibility throughout our internal policies
- Employ formal accessibility quality assurance methods
The Web Content Accessibility Guidelines (WCAG) defines requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA. Seelos Therapeutics is fully conformant with WCAG 2.1 level AA. Fully conformant means that the content fully conforms to the accessibility standard without any exceptions.
We welcome your feedback on the accessibility of the Seelos Therapeutics website. Please let us know if you encounter accessibility barriers on Seelos Therapeutics:
We try to respond to feedback within two (2) business days.
This statement was created on 12 December 2018 using the W3C Accessibility Statement Generator Tool.